Optimal Bupropion Dose for Smoking Cessation
The optimal dose of bupropion for smoking cessation is 150 mg twice daily (300 mg total daily) of the sustained-release (SR) formulation, started 1-2 weeks before the target quit date and continued for 7-12 weeks. 1, 2
Standard Dosing Protocol
Titration Schedule:
- Start with 150 mg once daily for the first 3 days 1, 2
- Increase to 150 mg twice daily (300 mg total) from day 4 onward 1, 2
- Begin treatment 1-2 weeks before the target quit date to establish therapeutic drug levels 1, 2
- Continue for 7-12 weeks total, with efficacy assessed at the end of this period 1, 2
Critical Maximum Dose:
- Never exceed 300 mg per day for smoking cessation to maintain seizure risk at 0.1% 1, 2
- This maximum is lower than the 450 mg daily limit used for depression treatment 1
Efficacy Data
The evidence strongly supports this dosing regimen:
- Bupropion 300 mg/day increases 12-month quit rates from approximately 11-16% with placebo to 19-30% 2, 3
- This represents a 9-10 percentage point improvement in sustained abstinence rates 1, 4
- The efficacy appears independent of bupropion's antidepressant effects 2
- Combination with behavioral support is essential, as published efficacy data primarily comes from studies including behavioral interventions 1, 2
Timing Considerations to Minimize Side Effects
To prevent insomnia (the most common side effect):
- Take the first dose in the morning 1, 5
- Take the second dose before 3 PM 1, 5
- This timing leverages bupropion's activating properties while minimizing sleep disturbance 1
Dose Adjustments for Special Populations
Hepatic Impairment:
Renal Impairment:
- GFR <90 mL/min: Reduce total daily dose by half 1, 5, 2
- Close monitoring required as bupropion and metabolites accumulate with renal dysfunction 5
Older Adults (≥55 years):
- Start with 37.5 mg once daily in the morning 5
- Increase by 37.5 mg every 3 days as tolerated 5
- Maximum dose remains 150 mg twice daily (300 mg total) 5
Absolute Contraindications
Do not prescribe bupropion if the patient has:
- Any seizure disorder (seizure risk approximately 1 in 1,000) 1, 2, 4
- Current or recent MAOI use (within 14 days) 1, 2
- Eating disorders (bulimia or anorexia nervosa) due to increased seizure risk 1, 5
- Severe hepatic cirrhosis 2, 4
- Abrupt discontinuation of alcohol, benzodiazepines, or antiepileptic drugs 1
- Uncontrolled hypertension 1, 5, 2
Critical Monitoring Parameters
Before Starting:
- Screen for seizure risk factors 2, 4, 6
- Obtain psychiatric history and assess suicide risk, especially in patients <24 years 2
- Check baseline blood pressure 5, 2
During Treatment:
- Monitor blood pressure periodically, especially in first 12 weeks 5, 2
- Watch for neuropsychiatric symptoms: hostility, agitation, depressed mood, suicidal thoughts (particularly in patients <24 years) 1, 2
- Assess efficacy at 7-12 weeks; if no significant progress toward abstinence, reassess treatment 1, 2
Clinical Advantages
Bupropion may be particularly beneficial for:
- Patients with comorbid depression who want to quit smoking, addressing both conditions simultaneously 1, 2
- Patients concerned about weight gain, as bupropion limits post-cessation weight gain compared to placebo 1, 7, 3
Common Pitfalls to Avoid
- Do not exceed 300 mg/day for smoking cessation - higher doses increase seizure risk without improving efficacy 1, 2
- Do not start treatment on the quit date - begin 1-2 weeks early to establish therapeutic levels 1, 2
- Do not dose late in the day - second dose after 3 PM increases insomnia risk 1, 5
- Do not use in patients taking tamoxifen - bupropion may reduce tamoxifen efficacy 1, 5